Neurotherapeutics
 | |
| Discipline | Neurology |
|---|---|
| Language | English |
| Edited by | Maral Mouradian |
| Publication details | |
| History | 2004-present |
| Publisher | Elsevier Inc. on behalf of the American Society for Experimental NeuroTherapeutics |
| Frequency | Quarterly |
| 5.6 (2020) | |
| Standard abbreviations | |
| ISO 4 | Neurotherapeutics |
| Indexing | |
| ISSN | 1933-7213 (print) 1878-7479 (web) |
| LCCN | 2006215616 |
| OCLC no. | 82448136 |
| Links | |
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Elsevier Inc. on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
Abstracting and indexing
[edit]The journal is abstracted and indexed in:
- Science Citation Index Expanded
- Index Medicus/PubMed/MEDLINE
- Scopus
- PsycINFO
- EMBASE
- Chemical Abstracts Service
- EBSCO databases
- Academic OneFile
- Current Contents/Life Sciences
- Current Contents/Clinical Medicine
According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620.[1]
References
[edit]- ^ "Neurotherapeutics". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2020.